Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 More Affordable Drugs To further assist China’s low-income groups in terms of healthcare av - Medical Product Outsourcing

More Affordable Drugs To further assist China’s low-income groups in terms of healthcare av

More Affordable Drugs


To further assist China’s low-income groups in terms of healthcare availability and affordability, the government also expanded the National Reimbursement Drug List (NRDL) in 2009 and further issued the Essential Drug List (EDL).


The NRDL is China’s main reference for drug reimbursement for basic medical insurance. The NRDL contains 2,127 drugs, which has 277 more drugs listed than the previous NRDL (revised in 2005). The additions to the NRDL list means more drugs are reimbursed through medical insurance.


The EDL, on the other hand, lists all essential medicines to be used at public health facilities, retail drugstores and medical institutions in China. These medicines are sold to patients at government-controlled prices in China healthcare institutions at a shared (co-pay) low price.

Prices of EDL drugs are fixed. No commission is paid for their prescription. This implies that there is no mark-up on these prices. As a consequence, the EDL drug prices will be reduced by as much as 50 percent. These drugs offer very low margins amid a competitive generic drug market in China.


Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters